Role of Testing for ADAMTS13 enzyme deficiency in patients with clots after Covid-19 infection and/or AstraZeneca vaccine.
Listening to the recent data on the rare but evolving probable correlation between clots and vaccine, I would like to know whether the patients with the clots have been tested for their ADAMTS13 enzyme assay? Could there be any inherent or acquired enzyme deficiency, due to ?autoantibodies to the enzyme as has been seen with Thrombotic Thrombocytopenic Purpura? In addition, was plasma exchange offered to these patients in intensive care?
I look forward to your response.
Dr. Ruchi Arora
Competing interests: No competing interests